ECL

Ecolab Declares Regular Dividend

Retrieved on: 
Thursday, February 24, 2022
Science, Other Science, Environment, Other Manufacturing, General Health, Health, Chemicals, Plastics, Manufacturing, Health, Hygiene, Food safety, ECL, Food, Water, Holding company, Pharmaceutical industry, Ecolab

The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.51 per common share, to be paid April 15, 2022, to shareholders of record at the close of business on March 15, 2022.

Key Points: 
  • The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.51 per common share, to be paid April 15, 2022, to shareholders of record at the close of business on March 15, 2022.
  • Ecolab has paid cash dividends on its common stock for 85 consecutive years.
  • A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services that help protect people, planet and business health.
  • www.ecolab.com

Ortelius Nominates Six Highly Qualified and Independent Candidates for Election to the Board of Directors of Trecora Resources

Retrieved on: 
Monday, February 7, 2022
Consulting, Professional Services, Finance, ECL, U.S. Securities and Exchange Commission, WHEN, IPI, SCL, Pangaea, Ownership, Peer group, NYSE, Kate Richard, Chemistry, SEC, American Vanguard Corporation, LLC, University, Industry, Risk management, Doctor of Philosophy, Company, Bermuda, Marketing, Audit committee, Knowledge, Security (finance), Inc. (magazine), FF, Chase Corporation, NO, SiGNa chemistry, Gas, Evonik Industries, AVD, Acquisition, Patent, Intrepid Potash, Abraham Ortelius, The Carlyle Group, Risk, University of Texas at Austin, Stepan Company, Plastic, THE, Finance, Common stock, CMT, Water, BCPC, Shareholder, Morgan Stanley, FTK, S.A, Core Molding Technologies, Investment, AMEX, UPON, CCF, Nasdaq, CCR, Management, Ecolab

We believe David Johnsons extensive investment management expertise and governance experience make him an ideal director candidate for Trecoras Board.

Key Points: 
  • We believe David Johnsons extensive investment management expertise and governance experience make him an ideal director candidate for Trecoras Board.
  • He has served as an independent director at Liquidia Corporation since April 2021.
  • If elected, Mr. Johnsons insights into financial strategy and organizational and business development would be invaluable to Trecoras Board.
  • We believe Michael Lefenfelds leadership experience as an innovation-focused chemicals business founder and executive make him an ideal director candidate for Trecoras Board.

ATN acquires exclusive Broadcast rights for European Cricket League 2022

Retrieved on: 
Thursday, February 3, 2022
Music, News, CEO, ATN Cricket Plus, NDTV, Satellite, Television, Sirius XM, Channel, Republic TV, Republic, FOOD, Bell Media, Radio, Bollywood, LIVE, European Cricket League, IPL, COVID-19, CBN, Partnership, Amazon, Multicultural Broadcasting, Company, ECL, Crave, Art, Jaya TV, UK, T-20, Sony Entertainment Television, ARY, ATN, Zee TV, Film, Cricket, Viacom

TORONTO, Feb. 3, 2022 /CNW/ - Asian Television Network International Limited (ATN) (TSXV:SAT), Canada's largest South Asian Broadcaster and pioneer broadcaster of Cricket, is pleased to announce that it has acquired exclusive Canadian Broadcast rights for European Cricket League 2022.

Key Points: 
  • TORONTO, Feb. 3, 2022 /CNW/ - Asian Television Network International Limited (ATN) (TSXV:SAT), Canada's largest South Asian Broadcaster and pioneer broadcaster of Cricket, is pleased to announce that it has acquired exclusive Canadian Broadcast rights for European Cricket League 2022.
  • The European Cricket League is a professional Ten10 cricket league contested by the best cricket clubs of European countries.
  • The second staging of ECL 2022 will take place from February 7th to March 18th, 2022 in Cartama, Spain.
  • ATN is also a pioneer broadcaster of Cricket in Canada and has exclusive broadcast rights for various International Cricket Boards.

Ecolab Life Sciences Announces 12% Price Increase

Retrieved on: 
Friday, January 21, 2022
Chemicals, Plastics, Energy, Manufacturing, Other Health, Technology, Pharmaceutical, General Health, Environment, Other Technology, Other Manufacturing, Science, Biotechnology, Other Science, Health, Utilities, Food safety, Hygiene, Inc., Food, ECL, Life, NYSE, Health, Compliance, Efficiency, Solution, Water, List of life sciences, Ecolab

Pricing for the Life Sciences segment programs will increase 12% globally.

Key Points: 
  • Pricing for the Life Sciences segment programs will increase 12% globally.
  • As our Life Sciences customers are working to create life changing solutions, our focus is to continue providing leading innovation, service support and end-to-end solutions that help improve contamination control practices and reduce their total cost of operation, said Surachet Tanwongsval, vice president and general manager, Global Life Sciences.
  • Ecolab Life Sciences provides advanced contamination control programs, products and services to help customer sites critical to public health mitigate risk and maximize uptime and productivity and maintain business continuity, efficiency and compliance.
  • Ecolab Life Sciences account managers will be available for customers to discuss the impact of these increases on their Ecolab program.

Ecolab Expects Strong 4Q 2021 Sales Growth but Lower Than Expected EPS Growth Due to COVID & Supply Chain Disruptions; Expects Low-Teens Adjusted EPS Growth in Full-Year 2022

Retrieved on: 
Thursday, January 20, 2022
Chemicals, Plastics, Utilities, Environment, Technology, Manufacturing, Other Technology, Energy, Transfer, Income, Forecasting, Vaccination, News, GAAP, Health, Vaccine, Private Securities Litigation Reform Act, SEC, Form 10-K, Nalco Water, Corporation, Growth, Weather, Terrorism, Disease, Solution, Government, Â, Food safety, Hygiene, Pandemic, U.S. Securities and Exchange Commission, ECL, Acquisition, Information technology, Phrase, Efficiency, Food, Epidemic, Water, Environment, Employment, Sale, Communication, Pressure, Enterprise resource planning, Security (finance), Terminology, COVID, Renewable energy, Risk management, Pharmaceutical industry, Bank, Insurance, Ecolab, COVID-19

Ecolab also absorbed significant short-term cost increases to assure seamless customer supply in a very tight environment that impacted margins in the short-term.

Key Points: 
  • Ecolab also absorbed significant short-term cost increases to assure seamless customer supply in a very tight environment that impacted margins in the short-term.
  • Fourth quarter and full year 2021 results remain subject to our normal year-end accounting and financial reporting procedures.
  • Ecolab expects to report fourth quarter 2021 results February 15, 2022.
  • We enter 2022 not with the environment we expected, but with the underlying momentum we wanted to have.

Ecolab Ranks #33 on Corporate Knights’ 2022 List of the World’s Most Sustainable Corporations

Retrieved on: 
Wednesday, January 19, 2022
Other Manufacturing, Environment, Infectious Diseases, Other Energy, Manufacturing, Other Natural Resources, Energy, General Health, Health, Natural Resources, Research, Health, Corporate Knights, Corporation, Knight, Inc., Workplace, Solution, Food safety, Hygiene, ECL, Goal, Food, Water, Environment, Workforce, Management, Renewable energy, Ecolab, Ecolab, Corporate Knights, ECOLAB, CORPORATE KNIGHTS

Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, has again been named to Corporate Knights index of the 100 Most Sustainable Corporations in the World, ranking #33 on the 2022 list.

Key Points: 
  • Ecolab Inc., the global leader in water, hygiene and infection prevention solutions and services, has again been named to Corporate Knights index of the 100 Most Sustainable Corporations in the World, ranking #33 on the 2022 list.
  • This is the fourth time Ecolab has appeared on the Global 100 Index since 2015.
  • We are honored to be included in this exclusive index of corporations that are leaders in delivering the right results, the right way, said Ecolab President and CEO Christophe Beck.
  • www.ecolab.com
    Corporate Knights Inc. includes the sustainable-business magazine Corporate Knights and a research division that produces rankings and financial product ratings based on corporate sustainability performance.

Ecolab Schedules Webcast and Conference Call on February 15

Retrieved on: 
Tuesday, January 11, 2022
Environment, Hospitals, Utilities, Chemicals, Plastics, Manufacturing, Energy, Restaurant, Bar, Food, Beverage, Health, Retail, Food safety, Hygiene, Webcast, Food, ECL, Health, Solution, Water, Dietary supplement, Pharmaceutical industry, Tissue paper, Ecolab

A replay of the webcast and supplemental data will be available on Ecolabs website.

Key Points: 
  • A replay of the webcast and supplemental data will be available on Ecolabs website.
  • A trusted partner at nearly three million customer locations, Ecolab (ECL) is the global leader in water, hygiene and infection prevention solutions and services.
  • With annual sales of $12 billion and more than 44,000 associates, Ecolab delivers comprehensive solutions, data-driven insights and personalized service to advance food safety, maintain clean and safe environments, optimize water and energy use, and improve operational efficiencies and sustainability for customers in the food, healthcare, hospitality and industrial markets in more than 170 countries around the world.
  • www.ecolab.com

Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Retrieved on: 
Tuesday, January 4, 2022
Ophthalmology, Allergan, PPL, Flow cytometry, The Carlyle Group, FP, Development, Solution, Spasticity, ECL, Fluorescence, McNeil Consumer Healthcare, API, PCC, G protein-coupled receptor, CDMO, Contract research organization, Biology, PPS, Pain management, Contract, Fine chemical

MUMBAI, India, Jan. 4, 2022 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today announced that the company has made a multi-million dollar investment to create a world-class high-throughput screening facility that will augment the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India. This new expansion, which is expected to go live in Q3 2022, will significantly add to the primary and secondary screening capabilities of compounds prepared at the Ahmedabad site.

Key Points: 
  • With integrated chemistry and biology services now available from a single site, we anticipate significant improvements to drug discovery cycle times.
  • In addition, new personnel with experience in biology services are being added to the site team, complementing the existing technical and operational expertise.
  • With this investment, we are enhancing our discovery platform by adding new in vitro biology services to our existing capabilities, making us a more integrated partner."
  • Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle.

Piramal Pharma Solutions Expands In Vitro Biology Capabilities at Ahmedabad Discovery Services Site

Retrieved on: 
Tuesday, January 4, 2022
Ophthalmology, Allergan, PPL, Flow cytometry, The Carlyle Group, FP, Development, Solution, Spasticity, ECL, Fluorescence, McNeil Consumer Healthcare, API, PCC, G protein-coupled receptor, CDMO, Contract research organization, Biology, PPS, Pain management, Contract, Fine chemical

MUMBAI, India, Jan. 4, 2022 /PRNewswire/ -- Piramal Pharma Limited's Pharma Solutions (PPS) business, a leading Contract Research, Development and Manufacturing Organization (CDMO), today announced that the company has made a multi-million dollar investment to create a world-class high-throughput screening facility that will augment the existing in-vitro biology capabilities at its drug discovery services site in Ahmedabad, India. This new expansion, which is expected to go live in Q3 2022, will significantly add to the primary and secondary screening capabilities of compounds prepared at the Ahmedabad site.

Key Points: 
  • With integrated chemistry and biology services now available from a single site, we anticipate significant improvements to drug discovery cycle times.
  • In addition, new personnel with experience in biology services are being added to the site team, complementing the existing technical and operational expertise.
  • With this investment, we are enhancing our discovery platform by adding new in vitro biology services to our existing capabilities, making us a more integrated partner."
  • Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle.

Ecolab Again Recognized for Global Water Leadership on CDP A List

Retrieved on: 
Tuesday, December 14, 2021
Other Manufacturing, Environment, Infectious Diseases, Hospitals, Chemicals, Plastics, Utilities, Manufacturing, Energy, Health, Zero, Organization, Water, Inc., Goal, COP26, Solution, Leadership, Global Business Coalition, Forest, Ambition, City, Awareness, Water resources, NYSE, U.N, Private sector, ECL, Health, Risk, Science, Corporation, CEO, CDP, Hygiene, Climate change, Food safety, Climate, List, Disclosure, Partnership, Food, Carbon, Risk management, Renewable energy, Explosive, Ecolab

Ecolab Inc. (NYSE:ECL), the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has again been recognized for its corporate sustainability leadership by global environmental non-profit CDP, earning inclusion on CDPs prestigious A List for tackling water security.

Key Points: 
  • Ecolab Inc. (NYSE:ECL), the global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources, has again been recognized for its corporate sustainability leadership by global environmental non-profit CDP, earning inclusion on CDPs prestigious A List for tackling water security.
  • This is the third consecutive year Ecolab has been recognized on the Water A List.
  • Our inclusion on CDPs water security A List reflects the work we do every day to help our customers advance their water and climate and net-zero goals, said Ecolab President and CEO Christophe Beck.
  • Of the nearly 12,000 companies that were evaluated, Ecolab is one of 118 high-performing companies named to the water security A List.